| 查看: 533 | 回复: 1 | ||
[求助]
翻译一段话，谢啦各位
|
|
There appears to be some room for manoeuvre in the legislation with regard to the interpretation of ‘‘good clinical practice.’’ Instead of accepting each new layer of bureaucracy the academic com-munity should clarify these developments, using legal advice where necessary. The cost-effectiveness of the type of procedures that ICH GCP generates is untested. For example, it has been estimated that the cost of a single ‘‘data query’’ is US$150. Robert Califf notes that this is a ‘‘colossal waste of money,’’ and that a more effective and scientific method would be to use sampling and the statistical process control techniques that are found in other indus-tries (such as engineering and manufac-turing) [41]. In short, there is no evidence that the intense bureaucracy of centralised politically driven procedures for ICH GCP has improved the care of trial participants in any way |
回复此楼» 猜你喜欢
一志愿北交大材料工程总分358求调剂
已经有6人回复
-
312求调剂
已经有7人回复
-
材料334求调剂
已经有19人回复
-
生物与医药273求调剂
已经有6人回复
-
301求调剂
已经有10人回复
-
专硕0854初试考材科基，求调剂
已经有5人回复
-
0703化学
已经有15人回复
-
0703调剂，一志愿天津大学319分
已经有9人回复
-
085600材料与化工301分求调剂院校
已经有10人回复
-
求调剂
已经有8人回复
2楼2013-08-11 20:41:24
